These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34750084)

  • 1. Dose to pelvic lymph nodes during brachytherapy of locally advanced cervical cancer with 60Co HDR source.
    Siavashpour Z; Aghili M; Anjidani S; Zayeri F; Moghani MM; Maleki M; Jaberi R
    Brachytherapy; 2022; 21(2):158-169. PubMed ID: 34750084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose to pelvic lymph nodes in locally advanced cervical cancer during high-dose-rate brachytherapy with tandem-ring applicators.
    Moghani MM; Siavashpour Z; Ogorodniitchouk O; Moreno-Acosta P; Plattard D; Vallard A; Sotton S; Bouleftour W; Langrand-Escure J; Magné N
    J Contemp Brachytherapy; 2022 Apr; 14(2):183-188. PubMed ID: 35494178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Image-Guided Brachytherapy a Comparison Between 192Ir and 60Co Sources in Carcinoma Uterine Cervix.
    Sinnatamby M; Kandasamy S; Karunanidhi G; Neelakandan V; Ramapandian S; Kannan M; Sampath E
    Gulf J Oncolog; 2022 Jan; 1(38):7-14. PubMed ID: 35156639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of point B and lymph node dose in 3D-planned high-dose-rate cervical cancer brachytherapy.
    Lee LJ; Sadow CA; Russell A; Viswanathan AN
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):803-9. PubMed ID: 19286328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer.
    Tanderup K; Fokdal LU; Sturdza A; Haie-Meder C; Mazeron R; van Limbergen E; Jürgenliemk-Schulz I; Petric P; Hoskin P; Dörr W; Bentzen SM; Kirisits C; Lindegaard JC; Pötter R
    Radiother Oncol; 2016 Sep; 120(3):441-446. PubMed ID: 27350396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reporting and validation of gynaecological Groupe Euopeen de Curietherapie European Society for Therapeutic Radiology and Oncology (ESTRO) brachytherapy recommendations for MR image-based dose volume parameters and clinical outcome with high dose-rate brachytherapy in cervical cancers: a single-institution initial experience.
    Mahantshetty U; Swamidas J; Khanna N; Engineer R; Merchant NH; Deshpande DD; Shrivastava S
    Int J Gynecol Cancer; 2011 Aug; 21(6):1110-6. PubMed ID: 21633296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unique role of proximal rectal dose in late rectal complications for patients with cervical cancer undergoing high-dose-rate intracavitary brachytherapy.
    Cheng JC; Peng LC; Chen YH; Huang DY; Wu JK; Jian JJ
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):1010-8. PubMed ID: 14575832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delineating the relationship between Point A prescription dose and pelvic lymph node doses in intracavitary high-dose-rate brachytherapy treatment of cervical cancer for use in low- and middle-income countries.
    Weaver J; Harmon G; Harkenrider MM; Surucu M; Wood A; Alite F; Small W
    Brachytherapy; 2018; 17(1):201-207. PubMed ID: 29066085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The equivalent dose contribution from high-dose-rate brachytherapy to positive pelvic lymph nodes in locally advanced cervical cancer.
    Lee YC; Rash DL; Stern RL; Mayadev JS
    Brachytherapy; 2013; 12(6):555-9. PubMed ID: 23880417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direction modulated brachytherapy (DMBT) for treatment of cervical cancer: A planning study with
    Safigholi H; Han DY; Mashouf S; Soliman A; Meigooni AS; Owrangi A; Song WY
    Med Phys; 2017 Dec; 44(12):6538-6547. PubMed ID: 28940520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
    Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
    Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of image-guided adaptive brachytherapy to pelvic nodes treatment in locally advanced cervical cancer.
    Bacorro W; Dumas I; Levy A; Rivin Del Campo E; Canova CH; Felefly T; Huertas A; Marsolat F; Haie-Meder C; Chargari C; Mazeron R
    Brachytherapy; 2017; 16(2):366-372. PubMed ID: 28159552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between the ICRU rectal point and modern volumetric parameters in brachytherapy for locally advanced cervical cancer.
    Mazeron R; Kamsu Kom L; Rivin del Campo E; Dumas I; Farha G; Champoudry J; Chargari C; Martinetti F; Lefkopoulos D; Haie-Meder C
    Cancer Radiother; 2014 Jun; 18(3):177-82. PubMed ID: 24751222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of radiation doses to the para-aortic, pelvic, and inguinal lymph nodes delivered by image-guided adaptive brachytherapy in locally advanced cervical cancer.
    Mohamed SM; Aagaard T; Fokdal LU; Pedersen EM; Lindegaard JC; Tanderup K
    Brachytherapy; 2015; 14(1):56-61. PubMed ID: 25176182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiobiological and dosimetric comparison of 60Co versus 192Ir high-dose-rate intracavitary-interstitial brachytherapy for cervical cancer.
    Wen A; Wang X; Wang B; Yan C; Luo J; Wang P; Li J
    Radiat Oncol; 2022 Dec; 17(1):206. PubMed ID: 36514118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the anatomical position of point B and the relationship between point B dose and the dose delivered to pelvic lymph nodes in CT-based high-dose-rate brachytherapy for uterine cervical cancer.
    Matsukawa H; Sasaki T; Hirayama R; Hirose TA; Fukunaga JI
    J Contemp Brachytherapy; 2019 Apr; 11(2):137-145. PubMed ID: 31139222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Point A vs. HR-CTV D
    Harmon G; Diak A; Shea SM; Yacoub JH; Small W; Harkenrider MM
    Brachytherapy; 2016; 15(6):825-831. PubMed ID: 27693173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survey of the use of the ICRU 38 in recording and reporting cervical cancer brachytherapy.
    Pötter R; Van Limbergen E; Gerstner N; Wambersie A
    Radiother Oncol; 2001 Jan; 58(1):11-8. PubMed ID: 11165676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
    Hashim N; Jamalludin Z; Ung NM; Ho GF; Malik RA; Phua VC
    Asian Pac J Cancer Prev; 2014; 15(13):5259-64. PubMed ID: 25040985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.